All Stories

  1. Development of dual drug loaded-hydrogel scaffold combining microfluidics and coaxial 3D-printing for intravitreal implantation
  2. Metabolomic changes in tear fluid following zinc biofortification in the BiZiFED nutritional study: a feasibility study
  3. Bruch's Membrane Calcification in Pseudoxanthoma Elasticum
  4. Retina pathology as a target for biomarkers for Alzheimer's disease: Current status, ophthalmopathological background, challenges, and future directions
  5. Reduced Cone Density Is Associated with Multiple Sclerosis
  6. Artificial intelligence for biomarker discovery in Alzheimer's disease and dementia
  7. Two-Photon Excited Fluorescence Lifetime Imaging of Tetracycline-Labeled Retinal Calcification
  8. Editorial: Zinc in health and disease management
  9. Altered zinc homeostasis in a primary cell culture model of the retinal pigment epithelium
  10. Fluorescence Lifetime Imaging of Human Sub-RPE Calcification In Vitro Following Chlortetracycline Infusion
  11. Optimised plasma sample preparation and LC‐MS analysis to support large‐scale proteomic analysis of clinical trial specimens: Application to the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) trial
  12. Zinc Supplementation Induced Transcriptional Changes in Primary Human Retinal Pigment Epithelium: A Single-Cell RNA Sequencing Study to Understand Age-Related Macular Degeneration
  13. Retinal Vascular Changes in Alzheimer's Dementia and Mild Cognitive Impairment: A Pilot Study Using Ultra-Widefield Imaging
  14. Ocular Biomarkers for Alzheimer Disease Dementia
  15. Zinc supplementation induced transcriptional changes in primary human retinal pigment epithelium: a single cell RNA sequencing study to understand age-related macular degeneration
  16. Nuclear and cellular, micro and nano calcification in Alzheimer's disease patients and correlation to phosphorylated Tau
  17. Re: Keenan et al.: Cluster Analysis and Genotype-Phenotype Assessment of Geographic Atrophy in Age-Related Macular Degeneration: AREDS2 Report 25 (Ophthalmology. 2021;5(11):1061-1073)
  18. A 2,7-dichlorofluorescein derivative to monitor microcalcifications
  19. A Potential New Role for Zinc in Age-Related Macular Degeneration through Regulation of Endothelial Fenestration
  20. Development of a Genotype Assay for Age-Related Macular Degeneration
  21. Characterization of Calcium Phosphate Spherical Particles in the Subretinal Pigment Epithelium–Basal Lamina Space in Aged Human Eyes
  22. Comment and response to the article “The clinical relevance of visualizing the peripheral retina”by Nicola Quinn, Lajos Csincsik, Erin Flynn, Christine A. Curcio, Szilard Kiss, SriniVas R. Sadda, Ruth Hogg, Tunde Peto & Imre Lengyel.
  23. Predicting Progression to Advanced Age-Related Macular Degeneration from Clinical, Genetic, and Lifestyle Factors Using Machine Learning
  24. Increased choroidal thickness in adults with Down syndrome
  25. Multiplex bioimaging of proteins-related to neurodegenerative diseases in eye sections by laser ablation - Inductively coupled plasma – Mass spectrometry using metal nanoclusters as labels
  26. Retinal phenotyping of variants of Alzheimer's disease using ultra‐widefield retinal images
  27. Genotype- and Phenotype-Based Subgroups in Geographic Atrophy Secondary to Age-Related Macular Degeneration
  28. Integrating Metabolomics, Genomics, and Disease Pathways in Age-Related Macular Degeneration
  29. A Multi-Omics Approach Identifies Key Regulatory Pathways Induced by Long-Term Zinc Supplementation in Human Primary Retinal Pigment Epithelium
  30. Fluorescent Arylphosphonic Acids: Synergic Interactions between Bone and the Fluorescent Core
  31. Nuclear and cellular, micro and nano calcification in Alzheimer’s disease patients and correlation to phosphorylated Tau
  32. Imaging hydroxyapatite in sub-retinal pigment epithelial deposits by fluorescence lifetime imaging microscopy with tetracycline staining
  33. Calcium, Diet, Imaging, and Age-Related Macular Degeneration
  34. Determination of Zn, Cu and Fe in human patients' serum using micro-sampling ICP-MS and sample dilution
  35. Correction to: Optic nerve thinning and neurosensory retinal degeneration in the rTg4510 mouse model of frontotemporal dementia
  36. Retinal thickness as potential biomarker in posterior cortical atrophy and typical Alzheimer’s disease
  37. P1‐273: ASSESSING HETEROGENEITY OF ALZHEIMER'S DISEASE THROUGH THE EYE
  38. Zinc Nutrition and Inflammation in the Aging Retina
  39. Metabolomics in serum of patients with non-advanced age-related macular degeneration reveals aberrations in the glutamine pathway
  40. THU0663 DO ANTIBODIES DIRECTED AGAINST HUMAN CILIARY BODY TISSUE PREDICT THE DEVELOPMENT OF UVEITIS IN JIA- A PRELIMINARY STUDY
  41. The Placental Growth Factor Pathway and Its Potential Role in Macular Degenerative Disease
  42. On the origin of proteins in human drusen: The meet, greet and stick hypothesis
  43. Deep and Frequent Phenotyping study protocol: an observational study in prodromal Alzheimer’s disease
  44. Increased High-Density Lipoprotein Levels Associated with Age-Related Macular Degeneration
  45. Mediterranean Diet and Incidence of Advanced Age-Related Macular Degeneration
  46. Fluorescence Lifetime Imaging of Tetracycline-Stained Retinal Hydroxyapatite: An Early Biomarker for Age-Related Macular Degeneration?
  47. Optic nerve thinning and neurosensory retinal degeneration in the rTg4510 mouse model of frontotemporal dementia
  48. Metabolomics and Age-Related Macular Degeneration
  49. Calcified nodules in retinal drusen are associated with disease progression in age-related macular degeneration
  50. A new perspective on lipid research in age-related macular degeneration
  51. The clinical relevance of visualising the peripheral retina
  52. Obesity, diabetes and zinc: A workshop promoting knowledge and collaboration between the UK and Israel, november 28–30, 2016 – Israel
  53. Precision medicine for age-related macular degeneration: current developments and prospects
  54. Genetic differences can cause changes in the level of several proteins in blood samples
  55. The effects of zinc supplementation on primary human retinal pigment epithelium
  56. Towards early detection of age-related macular degeneration with tetracyclines and FLIM
  57. Systemic and ocular fluid compounds as potential biomarkers in age-related macular degeneration
  58. Peripheral Retinal Imaging Biomarkers for Alzheimer’s Disease: A Pilot Study
  59. Localization of the zinc binding tubulin polymerization promoting protein in the mice and human eye
  60. Prevalence of Age-Related Macular Degeneration in Europe
  61. Changes in zinc status and zinc transporters expression in whole blood of patients with Systemic Inflammatory Response Syndrome (SIRS)
  62. Subretinal Pigment Epithelial Deposition of Drusen Components Including Hydroxyapatite in a Primary Cell Culture Model
  63. Main biomarkers associated with age-related plasma zinc decrease and copper/zinc ratio in healthy elderly from ZincAge study
  64. RETINAL IMAGING IN POSTERIOR CORTICAL ATROPHY AND TYPICAL ALZHEIMER’S DISEASE
  65. A Population-Based Ultra-Widefield Digital Image Grading Study for Age-Related Macular Degeneration–Like Lesions at the Peripheral Retina
  66. Retinal imaging in early-onset Alzheimer’s disease
  67. Retinal nerve fibre layer (RNFL) thinning in genetic ftd
  68. Correction for Thompson et al., Identification of hydroxyapatite spherules provides new insight into subretinal pigment epithelial deposit formation in the aging eye
  69. Identification of hydroxyapatite spherules provides new insight into subretinal pigment epithelial deposit formation in the aging eye
  70. Metals in age-related macular degeneration
  71. Zinc-induced self-association of complement C3b and Factor H: Implications for inflammation and age-related macular degeneration
  72. Zinc-induced Self-association of Complement C3b and Factor H: IMPLICATIONS FOR INFLAMMATION AND AGE-RELATED MACULAR DEGENERATION
  73. Zinc Binding to the Tyr402 and His402 Allotypes of Complement Factor H: Possible Implications for Age-Related Macular Degeneration
  74. The His402 allotype of complement factor H show similar self-association to the Tyr402 allotype but exhibits greater self-association in the presence of zinc
  75. Agreement between image grading of conventional (45°) and ultra wide-angle (200°) digital images in the macula in the Reykjavik eye study
  76. Bruch's membrane changes in transgenic mice overexpressing the human biglycan and apolipoprotein b-100 genes
  77. Uncontrolled Zinc- and Copper-Induced Oligomerisation of the Human Complement Regulator Factor H and Its Possible Implications for Function and Disease
  78. Uncontrolled zinc- and copper-induced oligomerisation of human complement factor H and its implications for age-related macular degeneration
  79. Reply to “Comment on: “High concentration of zinc in sub-retinal pigment epithelial deposits” (Lengyel et al.) (Exp. Eye Res. 772–780, 84/4, 2007)”
  80. Comment on: “High concentration of zinc in sub-retinal pigment epithelial deposits” (Lengyel et al.) (Exp. Eye Res. 772–780, 84/4, 2007)
  81. Cure or cause: opposing roles for zinc in age-related macular degeneration
  82. Bio‐avalibale zinc in the outer segments of short wavelength cones
  83. High concentration of zinc in sub-retinal pigment epithelial deposits
  84. Partial and full agonism in endomorphin derivatives: Comparison by null and operational model
  85. Autonomous activity of CaMKII is only transiently increased following the induction of long-term potentiation in the rat hippocampus
  86. Association of Drusen Deposition with Choroidal Intercapillary Pillars in the Aging Human Eye
  87. Enhancement of NMDA responses by β-amyloid peptides in the hippocampus in vivo
  88. Enhanced G-protein activation by a mixture of Abeta(25-35), Abeta(1-40/42) and zinc
  89. S100B-Mediated Inhibition of the Phosphorylation of GFAP Is Prevented by TRTK-12
  90. Molecular pathomechanisms of Alzheimer's disease
  91. Side Chain Modifications Change the Binding and Agonist Properties of Endomorphin 2
  92. Influence of Degradation on Binding Properties and Biological Activity of Endomorphin 1
  93. Receptor constants for endomorphin-1 and endomorphin-1-ol indicate differences in efficacy and receptor occupancy
  94. Preparation of specifically tritiated endomorphins
  95. Auto‐inhibition of Ca2+/calmodulin‐dependent protein kinase II by its ATP‐binding domain
  96. Autonomous activity and autophosphorylation of CAMPK‐II in rat hippocampal slices: effects of tissue preparation
  97. Modulation of the Phosphorylation and Activity of Calcium/Calmodulin‐Dependent Protein Kinase II by Zinc
  98. Phosphorylation of a New Brain-specific Septin, G-septin, by cGMP-dependent Protein Kinase
  99. Simultaneous measurement of tyrosine hydroxylase activity and phosphorylation in bovine adrenal chromaffin cells
  100. Phosphorylation of proteins in chick ciliary ganglion under conditions that induce long-lasting changes in synaptic transmission: phosphoprotein targets for nitric oxide action
  101. α and β subunits of CaM-kinase II are localized in different neurons in chick ciliary ganglion
  102. Characterization of protein kinase and phosphatase systems in chick ciliary ganglion
  103. Calcium/Calmodulin‐Stimulated Protein Kinase II Is Present in Primary Cultures of Cerebral Endothelial Cells
  104. Pathological Phosphorylation Causes Neuronal Death: Effect of Okadaic Acid in Primary Culture of Cerebellar Granule Cells
  105. Zinc can modulate the phosphorylation and activity of CAMK in freshly isolated rat brain capillaries
  106. Chapter 26: Regulation of transendothelial transport in the cerebral microvessels: the role of second messengers-generating systems
  107. Early X-irradiation of rats—4. Decrease in phosphorylation of low molecular weight proteins in the olfactory bulb accompanies the loss of GABAergic microneurons
  108. Kinetics of Protein Phosphorylation in Microvessels Isolated from Rat Brain: Modulation by Second Messengers